Analysis of KRAS, NRAS, BRAF and PIK3CA Mutations in Matched Primary and Metastatic Colorectal Carcinomas

被引：0
|
作者：
Vakiani, E. [1 ]
Janackinaram, M. [1 ]
Shia, J. [1 ]
Saltz, L. [1 ]
Kemeny, N. [1 ]
Weiser, M. [1 ]
Solit, D. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
716
引用
收藏
页码：171A / 171A
页数：1
相关论文
共 50 条
  • [21] Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases
    Baldus, Stephan E.
    Schaefer, Karl-L.
    Engers, Rainer
    Hartleb, Dinah
    Stoecklein, Nikolas H.
    Gabbert, Helmut E.
    CLINICAL CANCER RESEARCH, 2010, 16 (03) : 790 - 799
  • [22] Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer
    Kleist, Britta
    Kempa, Marcel
    Novy, Michael
    Oberkanins, Christian
    Xu, Li
    Li, Guojun
    Loland, Christiane
    Poetsch, Micaela
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 5927 - U1969
  • [23] KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal Cancer
    Zeng, Juanzi
    Fan, Wenwei
    Li, Jiaquan
    Wu, Guowu
    Wu, Heming
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 4109 - 4120
  • [24] KRAS, BRAF, PIK3CA MUTATIONS AND PTEN EXPRESSION IN HUMAN COLORECTAL CANCER - RELATIONSHIP WITH METASTATIC COLORECTAL CANCER
    Wang, X.
    Li, H.
    Lu, Y.
    Zhao, Q.
    ANNALS OF ONCOLOGY, 2010, 21 : 64 - 64
  • [25] EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
    Bujko, Mateusz
    Kober, Paulina
    Tysarowski, Andrzej
    Matyja, Ewa
    Mandat, Tomasz
    Bonicki, Wieslaw
    Siedlecki, Janusz Aleksander
    ONCOLOGY LETTERS, 2014, 7 (06) : 2019 - 2022
  • [26] Frequency and coexistence of KRAS, NRAS, BRAF and PIK3CA mutations and occurrence of MMR deficiency in Danish colorectal cancer patients
    Poulsen, Tim Svenstrup
    de Oliveira, Douglas Vinicius Nogueira Perez
    Espersen, Maiken Lise Marcker
    Klarskov, Louise Laurberg
    Skovrider-Ruminski, Wojciech
    Hogdall, Estrid
    APMIS, 2021, 129 (02) : 61 - 69
  • [27] Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
    De Roock, Wendy
    Claes, Bart
    Bernasconi, David
    De Schutter, Jef
    Biesmans, Bart
    Fountzilas, George
    Kalogeras, Konstantine T.
    Kotoula, Vassiliki
    Papamichael, Demetris
    Laurent-Puig, Pierre
    Penault-Llorca, Frederique
    Rougier, Philippe
    Vincenzi, Bruno
    Santini, Daniele
    Tonini, Giuseppe
    Cappuzzo, Federico
    Frattini, Milo
    Molinari, Francesca
    Saletti, Piercarlo
    De Dosso, Sara
    Martini, Miriam
    Bardelli, Alberto
    Siena, Salvatore
    Sartore-Bianchi, Andrea
    Tabernero, Josep
    Macarulla, Teresa
    Di Fiore, Frederic
    Gangloff, Alice Oden
    Ciardiello, Fortunato
    Pfeiffer, Per
    Qvortrup, Camilla
    Hansen, Tine Plato
    Van Cutsem, Eric
    Piessevaux, Hubert
    Lambrechts, Diether
    Delorenzi, Mauro
    Tejpar, Sabine
    LANCET ONCOLOGY, 2010, 11 (08): : 753 - 762
  • [28] Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases
    Jing Zhang
    Jianming Zheng
    Yinghong Yang
    Junliang Lu
    Jie Gao
    Tao Lu
    Jian Sun
    Hui Jiang
    Yan Zhu
    Yuhui Zheng
    Zhiyong Liang
    Tonghua Liu
    Scientific Reports, 5
  • [29] Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases
    Zhang, Jing
    Zheng, Jianming
    Yang, Yinghong
    Lu, Junliang
    Gao, Jie
    Lu, Tao
    Sun, Jian
    Jiang, Hui
    Zhu, Yan
    Zheng, Yuhui
    Liang, Zhiyong
    Liu, Tonghua
    SCIENTIFIC REPORTS, 2015, 5
  • [30] Mutational Status of KRAS, BRAF, NRAS and PIK3CA in Primary Clear Cell Ovarian Carcinoma
    Zannoni, Gian Franco
    Chiarello, Gaia
    Petrillo, Marco
    Improta, Giuseppina
    Rossi, Esther D.
    Fadda, Guido
    Fraggetta, Filippo
    MODERN PATHOLOGY, 2015, 28 : 316A - 317A
12345